Ekf Diagnostics Holding PLC (LON:EKF)‘s stock had its “corporate” rating reaffirmed by equities researchers at N+1 Singer in a research note issued on Monday.
A number of other analysts also recently issued reports on the stock. Panmure Gordon reissued a “buy” rating and set a GBX 19 ($0.24) price target on shares of Ekf Diagnostics Holding PLC in a report on Monday, November 7th. FinnCap reaffirmed an “under review” rating on shares of Ekf Diagnostics Holding PLC in a report on Tuesday, August 30th.
Ekf Diagnostics Holding PLC (LON:EKF) traded down 0.72% during trading on Monday, hitting GBX 17.25. 3,000 shares of the company were exchanged. The company’s market capitalization is GBX 73.96 million. The stock’s 50-day moving average is GBX 16.92 and its 200-day moving average is GBX 14.57. Ekf Diagnostics Holding PLC has a 12 month low of GBX 7.75 and a 12 month high of GBX 18.24.